Journey through ARSACS: Insights from a case series of seven patients - A single centre study and review of Indian cohort.

IF 2.5 4区 医学 Q2 CLINICAL NEUROLOGY Journal of Movement Disorders Pub Date : 2024-08-29 DOI:10.14802/jmd.24154
Mit Ankur Raval, Vikram V Holla, Nitish Kamble, Gautham Arunachal, Babylakshmi Muthusamy, Jitender Saini, Ravi Yadav, Pramod Kumar Pal
{"title":"Journey through ARSACS: Insights from a case series of seven patients - A single centre study and review of Indian cohort.","authors":"Mit Ankur Raval, Vikram V Holla, Nitish Kamble, Gautham Arunachal, Babylakshmi Muthusamy, Jitender Saini, Ravi Yadav, Pramod Kumar Pal","doi":"10.14802/jmd.24154","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In this study we describe the clinical, and investigations profile of 7 cases of autosomal-recessive spastic-ataxia of Charlevoix-Saguenay (ARSACS).</p><p><strong>Methods: </strong>We performed retrospective chart review of genetically proven cases of ARSACS from our database. Additionally, we reviewed literature for reported cases of ARSACS from India.</p><p><strong>Result: </strong>All seven patients had onset within the first-decade. As per the available data, all had walking difficulty (7/7), spastic-ataxia (7/7), classical neuroimaging findings (7/7), sensory-motor demyelinating polyneuropathy (6/6), abnormal evoked-potentials (5/5) and thickened retinal nerve fiber layer (3/3). Exome sequencing revealed 8 pathogenic/likely-pathogenic unique variants (6 novel) in SACS gene. Additional 21 cases (18 families) of ARSACS that could be identified from India had similar clinical and investigational findings. The most common c.8793delA variant may have a founder effect.</p><p><strong>Conclusion: </strong>Our series adds to the previously reported cases of ARSACS from India and expands the genetic spectrum by adding 6 novel variants.</p>","PeriodicalId":16372,"journal":{"name":"Journal of Movement Disorders","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Movement Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14802/jmd.24154","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In this study we describe the clinical, and investigations profile of 7 cases of autosomal-recessive spastic-ataxia of Charlevoix-Saguenay (ARSACS).

Methods: We performed retrospective chart review of genetically proven cases of ARSACS from our database. Additionally, we reviewed literature for reported cases of ARSACS from India.

Result: All seven patients had onset within the first-decade. As per the available data, all had walking difficulty (7/7), spastic-ataxia (7/7), classical neuroimaging findings (7/7), sensory-motor demyelinating polyneuropathy (6/6), abnormal evoked-potentials (5/5) and thickened retinal nerve fiber layer (3/3). Exome sequencing revealed 8 pathogenic/likely-pathogenic unique variants (6 novel) in SACS gene. Additional 21 cases (18 families) of ARSACS that could be identified from India had similar clinical and investigational findings. The most common c.8793delA variant may have a founder effect.

Conclusion: Our series adds to the previously reported cases of ARSACS from India and expands the genetic spectrum by adding 6 novel variants.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
ARSACS 之旅:从七名患者的系列病例中获得的启示--一项单一中心研究和印度队列回顾。
背景:在这项研究中,我们描述了7例常染色体隐性遗传的沙勒沃瓦-萨盖内痉挛性共济失调(ARSACS)患者的临床和检查情况:在这项研究中,我们描述了 7 例常染色体隐性遗传的沙勒沃瓦-萨古奈痉挛性共济失调(ARSACS)患者的临床和检查情况:我们对数据库中经基因证实的 ARSACS 病例进行了回顾性病历审查。此外,我们还查阅了印度有关 ARSACS 病例的文献:结果:所有七名患者均在最初十年内发病。根据现有数据,所有患者均有行走困难(7/7)、痉挛性共济失调(7/7)、典型神经影像学检查结果(7/7)、感觉运动脱髓鞘性多发性神经病(6/6)、诱发电位异常(5/5)和视网膜神经纤维层增厚(3/3)。外显子组测序显示,SACS 基因存在 8 个致病/可能致病的独特变异(6 个新变异)。从印度找到的另外 21 例(18 个家庭)ARSACS 患者也有类似的临床和检查结果。最常见的c.8793delA变异可能具有创始人效应:我们的系列研究增加了之前报告的印度 ARSACS 病例,并通过增加 6 个新型变异体扩大了遗传谱。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Movement Disorders
Journal of Movement Disorders CLINICAL NEUROLOGY-
CiteScore
2.50
自引率
5.10%
发文量
49
审稿时长
12 weeks
期刊最新文献
Adjustability of gait speed in clinics and free-living environments in people with Parkinson's disease. Goal Attainment Scale Refine Patient-Centred Expectations in Botulinum Toxin Treatment of Cervical Dystonia. Monitoring cognitive functions during deep brain stimulation (DBS) interventions by Real Time Neuropsychological Testing (DBS-RTNT). Clinico-genetic profile of seven patients with PARK-PINK1: A case series from a tertiary care centre from India and review of literature. Effect of positional change on cerebral perfusion in Parkinson's disease with orthostatic hypotension.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1